Biotin Labeled Human Fibrinogen
-
Catalog numberMI-FIB-BIO
-
PricePlease ask
-
Size10 mg
-
-
PropertiesBiotin conjugates can be detected by horseradish peroxidase, alkaline phosphatase substrates or anti biotin conjugated antibodies. Avidin and Streptavidin bind to the small biotin and are couple to HRP or AP for ELISA. To break the streptavidin Biotin bond we suggest to use a 6 molar guanidine HCl solution with acidity of pH 1.6. Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
-
ConjugationBiotinylated
-
DescriptionFITC labelling for flow cytometry of antibodies and peptides.
-
Gene target
-
Gene symbolFGG, FGB, FGA
-
Short nameFibrinogen
-
LabelBiotin
-
SpeciesHuman, Humans
-
Alternative namebiotinilated Labeled H. sapiens Fibrinogen
-
Gene info
-
Identity
-
Gene
-
Long gene namefibrinogen gamma chain
-
Synonyms gene name
- fibrinogen, gamma polypeptide
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- Fibrinogen C domain containing
- Receptor ligands
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namefibrinogen beta chain
-
Synonyms gene name
- fibrinogen, B beta polypeptide
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- Fibrinogen C domain containing
- Receptor ligands
-
VEGA ID
-
Locus Specific Databases
Gene info
-
Identity
-
Gene
-
Long gene namefibrinogen alpha chain
-
Synonyms gene name
- fibrinogen, A alpha polypeptide
-
Locus
-
Discovery year2001-06-22
-
Entrez gene record
-
RefSeq identity
-
Classification
- Fibrinogen C domain containing
- Receptor ligands
-
VEGA ID
-
Locus Specific Databases
MeSH Data
-
Name
-
ConceptScope note: Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
-
Tree numbers
- E05.916.310
-
Qualifierstrends, ethics, history, classification, economics, instrumentation, methods, standards, legislation & jurisprudence, statistics & numerical data